Finance Home - My Yahoo - Yahoo! - Help

Thursday, November 26, 2009, 9:04AM ET - U.S. Markets Closed for Thanksgiving Day. Dow  0.29% Nasdaq  0.32%

Nabi Biopharmaceuticals (NABI)

On Nov 25: 4.93   0.03 (0.61%)

MORE ON NABI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Company Events Get Company Events for:
UPCOMING EVENTS   Date Event Reminder No Upcoming Events RECENT EVENTS   Date Event 25-Nov-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Change in Directors or Principal Officers 17-Nov-09 Nabi Biopharmaceuticals Conference Call to discuss announcement of the exclusive worldwide option and licensing agreement for NicVAX(R) scheduled for 11:00 am ET today 16-Nov-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi 5-Nov-09 Nabi Biopharmaceuticals Earnings Call scheduled for 4:30 pm ET today 5-Nov-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and 5-Nov-09 Earnings announcement 6-Aug-09 Nabi Biopharmaceuticals Earnings Call scheduled for 4:30 pm ET today 6-Aug-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial S 31-Jul-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Change in Directors or Principal Officers 10-Jul-09 Price hit new 52-week low ($2.15) 8-Jul-09 Price hit new 52-week low ($2.20) 15-May-09 Price hit new 52-week low ($2.29) 6-May-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and 14-Apr-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Change in Directors or Principal Officers 11-Mar-09 NABI BIOPHARMACEUTICALS Files SEC form 10-K, Annual Report 11-Mar-09 NABI BIOPHARMACEUTICALS Files SEC form 8-K, Results of Operations and Financial Condition, Non-Reliance on Previous 6-Nov-08 NABI BIOPHARMACEUTICALS Files SEC form 10-Q, Quarterly Report
Add to Portfolio     Set Alert     Email to a Friend Get Company Events for Another Symbol: Symbol Lookup • Splits Calendar • Mergers & Acquisitions Calendar